複数のOITのアウトカムを改善するための生物学的薬を用いた2段階のランダム化制御試験 (COMBINE):設計,根拠,方法
A J Long1, S Sindher1, K Martinez1
1Department of Pathology, Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, United States.
No abstract available in PubMed .
さらに関連する動画
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
